Search research articles
Contact Us
Filters
Showing results (51-60 of 254) with videos related to
Page
of 26
Sort By:
Bioconjugate Chemistry
|
July 18, 2000
Evaluation of biotin-dye conjugates for use in an HPLC assay to assess relative binding of biotin derivatives with avidin and streptavidin
D S Wilbur, P M Pathare, D K Hamlin, et al.
The Journal of Nutrition
|
February 1, 1996
Vitamin A status of Indonesian children infected with Ascaris lumbricoides after dosing with vitamin A supplements and albendazole
S A Tanumihardjo, D Permaesih, Muherdiyantiningsih, et al.
Immunotechnology : an International Journal of Immunological Engineering
|
December 16, 1998
Engineering the isoelectric point of a renal cell carcinoma targeting antibody greatly enhances scFv solubility
P H Tan, V Chu, J E Stray, et al.
Anesthesiology
|
May 1, 1990
Noninvasive cardiac output: simultaneous comparison of two different methods with thermodilution
D H Wong, K K Tremper, E A Stemmer, et al.
Acta Oncologica (Stockholm, Sweden)
|
January 1, 1994
Enhancement of fast neutron beams with boron neutron capture therapy. A mechanism for achieving a selective, concomitant tumor boost
T A Buchholz, G E Laramore, P Wootton, et al.
Bioconjugate Chemistry
|
February 14, 1998
Streptavidin in antibody pretargeting. Comparison of a recombinant streptavidin with two streptavidin mutant proteins and two commercially available streptavidin proteins
D S Wilbur, P S Stayton, R To, et al.
Biomolecular Engineering
|
May 5, 2000
Development of new biotin/streptavidin reagents for pretargeting
D S Wilbur, P M Pathare, D K Hamlin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 1, 1989
Development of a stable radioiodinating reagent to label monoclonal antibodies for radiotherapy of cancer
D S Wilbur, S W Hadley, M D Hylarides, et al.
Toxicology and Industrial Health
|
March 11, 2000
Agency for Toxic Substances and Disease Registry's 1997 priority list of hazardous substances. Latent effects--carcinogenesis, neurotoxicology, and developmental deficits in humans and animals
S R Ostrowski, S Wilbur, C H Chou, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 30, 1994
Boron neutron capture therapy: a mechanism for achieving a concomitant tumor boost in fast neutron radiotherapy
G E Laramore, P Wootton, J C Livesey, et al.
Page
of 26
Search research articles
Search
Showing results (51-60 of 254) with videos related to
Sort By:
Page
of 26
Bioconjugate Chemistry
|
July 18, 2000
Evaluation of biotin-dye conjugates for use in an HPLC assay to assess relative binding of biotin derivatives with avidin and streptavidin
D S Wilbur, P M Pathare, D K Hamlin, et al.
The Journal of Nutrition
|
February 1, 1996
Vitamin A status of Indonesian children infected with Ascaris lumbricoides after dosing with vitamin A supplements and albendazole
S A Tanumihardjo, D Permaesih, Muherdiyantiningsih, et al.
Immunotechnology : an International Journal of Immunological Engineering
|
December 16, 1998
Engineering the isoelectric point of a renal cell carcinoma targeting antibody greatly enhances scFv solubility
P H Tan, V Chu, J E Stray, et al.
Anesthesiology
|
May 1, 1990
Noninvasive cardiac output: simultaneous comparison of two different methods with thermodilution
D H Wong, K K Tremper, E A Stemmer, et al.
Acta Oncologica (Stockholm, Sweden)
|
January 1, 1994
Enhancement of fast neutron beams with boron neutron capture therapy. A mechanism for achieving a selective, concomitant tumor boost
T A Buchholz, G E Laramore, P Wootton, et al.
Bioconjugate Chemistry
|
February 14, 1998
Streptavidin in antibody pretargeting. Comparison of a recombinant streptavidin with two streptavidin mutant proteins and two commercially available streptavidin proteins
D S Wilbur, P S Stayton, R To, et al.
Biomolecular Engineering
|
May 5, 2000
Development of new biotin/streptavidin reagents for pretargeting
D S Wilbur, P M Pathare, D K Hamlin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 1, 1989
Development of a stable radioiodinating reagent to label monoclonal antibodies for radiotherapy of cancer
D S Wilbur, S W Hadley, M D Hylarides, et al.
Toxicology and Industrial Health
|
March 11, 2000
Agency for Toxic Substances and Disease Registry's 1997 priority list of hazardous substances. Latent effects--carcinogenesis, neurotoxicology, and developmental deficits in humans and animals
S R Ostrowski, S Wilbur, C H Chou, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 30, 1994
Boron neutron capture therapy: a mechanism for achieving a concomitant tumor boost in fast neutron radiotherapy
G E Laramore, P Wootton, J C Livesey, et al.
Page
of 26